Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
    Open Access
    Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
    Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini, Donatella Arpa, Nicoletta Ranallo, Irene Azzali, Valentina Di Iorio, Anna Sarnelli, Monti Manuela, Elena Amadori, Lucia Fabbri, Daniela Bartolini, Luigino Tosatto, Francesco Di Meco, Lorena Gurrieri, Nada Riva, Luana Calabro, Federica Matteucci, Giovanni Paganelli and Maddalena Sansovini
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1409-1415; DOI: https://doi.org/10.2967/jnumed.123.266956
  • Total-Body Dynamic Imaging and Kinetic Modeling of [<sup>18</sup>F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
    Open Access
    Total-Body Dynamic Imaging and Kinetic Modeling of [18F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
    Negar Omidvari, Jelena Levi, Yasser G. Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E. Daly, Guobao Wang and Simon R. Cherry
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1481-1488; DOI: https://doi.org/10.2967/jnumed.123.267003
  • Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
    You have access
    Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
    John Nikitas, Angela Castellanos Rieger, Andrea Farolfi, Ameen Seyedroudbari, Amar U. Kishan, Nicholas G. Nickols, Michael L. Steinberg, Luca F. Valle, Matthew Rettig, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1387-1394; DOI: https://doi.org/10.2967/jnumed.124.267922
  • Role of <sup>64</sup>CuCl<sub>2</sub> PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and <sup>18</sup>F-FDG PET/CT
    You have access
    Role of 64CuCl2 PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and 18F-FDG PET/CT
    Arnoldo Piccardo, Gianluca Bottoni, Cristina Puppo, Michela Massollo, Martina Ugolini, Mehrdad Shoushtari Zadeh Naseri, Enrico Melani, Laura Tomasello, Monica Boitano, Andrea DeCensi, Beatrice Sambucco, Fabio Campodonico, Vania Altrinetti, Marco Ennas, Alessia Urru, Carlo Luigi Augusto Negro, Luca Timossi, Giorgio Treglia, Carlo Introini and Francesco Fiz
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1357-1363; DOI: https://doi.org/10.2967/jnumed.124.267474
  • Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
    You have access
    Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
    Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor and Ayse Tuba Kendi
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1402-1408; DOI: https://doi.org/10.2967/jnumed.124.267643
  • Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study
    Open Access
    Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study
    Siddhartha Baxi, Saima Vohra, Angela Hong, Nicola Mulholland, Martin Heuschkel, Gerhard Dahlhoff, Giuseppe Cardaci, Siroos Mirzaei and Mike Sathekge
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1450-1455; DOI: https://doi.org/10.2967/jnumed.124.267988
  • Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical Therapy
    You have access
    Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy
    Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell and Thomas A. Hope
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1395-1401; DOI: https://doi.org/10.2967/jnumed.124.267955
  • [<sup>68</sup>Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria
    You have access
    [68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria
    Ismini C. Mainta, Angeliki Neroladaki, Nicola Bianchetto Wolf, Daniel Benamran, Sana Boudabbous, Thomas Zilli and Valentina Garibotto
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1376-1382; DOI: https://doi.org/10.2967/jnumed.124.267899
  • Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
    You have access
    Theranostic Intratumoral Convection-Enhanced Delivery of 124I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
    Neeta Pandit-Taskar, Pat B. Zanzonico, Milan Grkovski, Maria Donzelli, Scott M. Vietri, Christopher Horan, Brian Serencsits, Kavya Prasad, Serge Lyashchenko, Kim Kramer, Ira J. Dunkel and Mark M. Souweidane
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1364-1370; DOI: https://doi.org/10.2967/jnumed.123.266365
  • Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT
    You have access
    Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT
    Sherrington Li, Andrew Nguyen, William Counter, Nikeith C. John, Jeremiah De Leon, George Hruby, Anthony M. Joshua, Phillip Stricker, Megan Crumbaker, Narjess Ayati, Lyn Chan, Zahra Sabahi, Mina Swiha, Andrew Kneebone, Keith Wong, Victor Liu, Shikha Sharma, Shikha Agrawal and Louise M. Emmett
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1371-1375; DOI: https://doi.org/10.2967/jnumed.124.267881

Pages

  • Previous
  • Next
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 91
SNMMI

© 2025 SNMMI

Powered by HighWire